Related content

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study

By Tıraş M.B.   Noyan V.   Yıldız A.   Yıldırım M.  

Human Reproduction, Vol. 15, Iss. 10, 2000-10 ,pp. : 2087-2092

Oxford University Press

Access to resources Recommend Favorite

Effects of specific post‐menopausal hormone therapies on bone mineral density in post‐menopausal women: a meta‐analysis

By Dören Martina  

Human Reproduction, Vol. 18, Iss. 8, 2003-08 ,pp. : 1737-1746

Oxford University Press

Access to resources Recommend Favorite

Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy

By Darabi Maryam   Rabbani Mohammed   Ani Mohsen   Zarean Elahe   Panjehpour Mojtaba   Movahedian Ahmad  

Gynecological Endocrinology, Vol. 27, Iss. 9, 2011-09 ,pp. : 701-705

Informa Healthcare

Access to resources Recommend Favorite

Assessment of mammographic density in postmenopausal women during long term hormone replacement therapy

By Carmona-Sánchez Encarnación   Cuadros López José L.   Cuadros Celorrio Ángela M.   Pérez-Roncero Gonzalo   González Ramírez Amanda R.   Fernández Alonso Ana M.  

Gynecological Endocrinology, Vol. 29, Iss. 12, 2013-12 ,pp. : 1067-1070

Informa Healthcare

Access to resources Recommend Favorite